Pfizer CentreOne, a global pharmaceutical CDMO embedded within Pfizer and a supplier of specialty APIs, has appointed Andrew Moore as general manager. This follows the outgoing general manager, JoyL Silva’s transition to vice president, global franchise lead for hematology and commercial excellence within Pfizer’s Oncology Division.
 
Moore is an experienced healthcare leader, innovator and entrepreneur, who began his healthcare career in sales and marketing, including seven years at Pfizer. He has also held leadership roles at AmerisourceBergen and McKesson.
 
Most recently, Moore was the CEO of CogxVision, a Carnegie Mellon University start-up company that applies artificial intelligence and machine learning to improve safety, outcomes, asset management and selling performance for the healthcare industry.
 
As the general manager of Pfizer CentreOne, Moore will spearhead the CDMO’s growth plans in the contract manufacturing sector with a focus on leveraging Pfizer’s extensive development and manufacturing capabilities in small molecule API, large molecule biologics, sterile injectables and oral solids. Additionally, he will continue to cement Pfizer CentreOne’s position as a supplier of quality steroid and hormone APIs and intermediates.
 
“Having previously worked for Pfizer, I am looking forward to leading Pfizer CentreOne to be the CDMO partner of choice,” said Moore. “I look forward to bringing a new perspective and an innovative mindset to the role, garnered from my most recent experience of leading a start-up company.”
 
Prior to his professional career, Moore served in the U.S. Army where he received multiple accolades, including the Bronze Star for his combat experience in Iraq Desert Storm. Moore holds an undergraduate degree from University of Southern Mississippi and participated in a MSBA graduate candidate degree program at Boston University in Heidelberg, Germany.